🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to learn if temozolomide alone ...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-08
Trial ID
NCT00525031
Treatments Being Tested
The purpose of this study is to evaluate the impact of a physician directed...
Status
Completed
Location
California Liver Institute
Start Date
2011-12
Trial ID
NCT01405027
Treatments Being Tested
This phase I trial is studying the side effects of decitabine when given to...
Status
Terminated
Location
Nevada Cancer Institute-Summerlin Campus
Start Date
2009-04
Trial ID
NCT00701298
Treatments Being Tested
The purpose of the study is to compare the efficacy and toxicity including ...
Status
Completed
Location
Dept of Hematology, Aalborg hospital
Start Date
2012-01
Trial ID
NCT01387763
RATIONALE: PEG-interferon alfa-2b may interfere with the growth of cancer c...
Status
Terminated
Location
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Start Date
2008-09
Trial ID
NCT00724061
Treatments Being Tested
This is an Australian, open-label, multicenter, randomized, double-blind cl...
Status
Terminated
Location
Multiple Locations
Start Date
2005-02
Trial ID
NCT00255034
Treatments Being Tested
The purpose of this interventional study is to determine the feasibility to...
Status
Completed
Location
Leiden University Medical Center
Start Date
2011-02
Trial ID
NCT01637532
Treatments Being Tested
The purpose of this study is to show the superiority of a 4 weeks lead-in p...
Status
Withdrawn
Location
NHTMRI
Start Date
2014-04
Trial ID
NCT02099604
Treatments Being Tested
We propose to test our primary hypothesis that treatment with Peg-IFN-α-2b ...
Status
Completed
Location
AIDS Clinical Trials Unit (ACTU), and Department of Medicine, University of Pennsylvania Perelman School of Medicine
Start Date
2013-08-07
Trial ID
NCT01935089
Treatments Being Tested
The purposes of the PLUS study were to confirm the safety and tolerability ...
Status
Completed
Location
Henry Ford Hospital
Start Date
2008-01
Trial ID
NCT00593151
Treatments Being Tested